CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 2
  • Morbidly obese patients aged 18–65 years
  • BMI >40 kg/m² or BMI >35 kg/m² with severe comorbidities (diabetes, sleep apnea, hypertension, etc.)
Key exclusion· 4
  • Psychiatric illness
  • Substance abuse
  • Previous gastrointestinal surgery
  • Patients who require conversion from laparoscopic to open procedure

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01026181
NCT01026181N/ACompleted

Phase II Study of Comparing Outcomes of Laparoscopic Sleeve Gastrectomy, Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Gastric Banding to Treat Morbid Obesity

University of Alberta·observational·Posted Dec 4, 2009·Updated Oct 3, 2017

In Brief

An observational study for Morbid Obesity. Completed, enrolled 150 participants.

Detailed Summary

This is a prospective case series study; all morbidly obese patients that need surgical management in Royal Alexandra Hospital will be provided 3 surgical options: Laparoscopic Sleeve Gastrectomy (LSG), laparoscopic Roux-en-Y gastric bypass (LR-en-Y), and laparoscopic gastric banding (LGB), safety and effectiveness will be compared among the 3 groups. The outcome measures will be percentage of excess weight loss, BMI, operative time, hospital stays, complications and improvement of comorbidities.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMorbid Obesity
Countries--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 4, 2009
Enrollment StartSep 1, 2008
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 16.6 years ago